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The  effect  of  livingstone  potato  (Plectranthus  esculenthus  N.E.Br)  on serum  glucose,  gly-
cated  hemoglobin  (HbA1C),  serum  triglyceride,  total  cholesterol,  high  density  lipoprotein
(HDL),  low  density  lipoprotein  (LDL),  very  low  density  lipoprotein  (VLDL),  hepatic  malic
enzyme  (ME),  isocitrate  dehydrogenase  (IDH)  and  catalase  activities  of Streptozotocin
induced  diabetic  rats  were  investigated  using  standard  techniques.  The  atherogenic  index
(AI)  and coronary  risk  index  (CRI) of  the  rats  were  calculated  as  the  ratios  of  LDL  to HDL
and total  cholesterol  to HDL,  respectively.  The  serum  glucose  of the  non-diabetic,  dia-
betic control  and  diabetic  rats  given  livingstone  potato  incorporated  feeds  (test  feed)  were
92.58 ±  3.97,  352.30  ±  4.88  and  165.50  ± 7.88 mg/dl,  respectively.  Intake  of  the  test feed
by the  diabetic  rats  of  group  3, resulted  in  signiﬁcant  (P < 0.05)  decrease  of  their serum
glucose,  HbA1c, triglyceride,  cholesterol,  LDL,  VLDL,  AI and  CRI  but  signiﬁcant  increase
(P  <  0.05)  of  hepatic  levels  of ME,  IDH,  catalase  and  serum  HDL  compared  with  the  dia-
betic  control  rats  that had  signiﬁcant  alteration  of  these  parameters  (P  <  0.05) compared
with  the  non-diabetic  rats.  The  feed  intakes  of  the  non-diabetic,  diabetic  control  and  dia-
betic  rats  given  the  test  feed  were  133.34  ±  1.32,  137.84  ± 5.77  and  146.38  ± 4.33  g/rat/week
by  the  last  week  of experimentation.  The  diabetic  control  rats  recorded  signiﬁcant  loss
of weight  (P < 0.05)  compared  with  the non  diabetic  rats  despite  increased  feed  intake.
Chemical  analysis  of  the standard  and  test  feeds  showed  that  the  standard  rat feed con-
tained  15.00  ±  0.78%  protein,  7.24 ± 1.20%  fat,  31.55  ±  2.62%  carbohydrates,  energy  value  of
290.65 ±  4.77  kcal/100  g, 10%  crude ﬁber  and 0.12  ± 0.04 mg  Gallic  Acid  Equivalent  while the
test  feed  contained  40.10  ±  0.16%  carbohydrates,  17.22 ± 0.40%  protein,  22.16  ±  0.34%  fat,Triethanolamine  (PubChem CID-7618)
NADP (PubChem CID-5886)
energy value  of  428.70  ±  2.12  kcal/100  g, 8.51  ± 0.16%  crude  ﬁber,  1.3  ±  0.2  mg  Gallic  Acid
Equivalent/g  of sample  and  strong  antioxidant  activity  comparable  to  standard  quercetin.
The  study  shows  the  pote
hyperlipidemia.
© 2014  The  Authors.  Publ
the CC  BY-NC
Abbreviations: HbA1c, glycated hemoglobin; IDH, isocitrate dehy-
drogenase; ME,  malic enzyme; AI, atherogenic index; CRI, coronary risk
index; HDL, high density lipoprotein; LDL, low density lipoprotein; VLDL,
very low density lipoprotein; GAE, gallic acid equivalence; NADPH, nico-
tinamide adenine dinucleotide phosphate reduced; NADP+, nicotinamide
adenine dinucleotide phosphate oxidized; NADH, nicotinamide adenine
dinucleotide reduced; NAD+, nicotinamide adenine dinucleotide oxidized.
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1. Introduction
The alteration of lipid metabolism is one of the major
causes of complications arising from diabetes mellitus as it
leads  to increased risk of cardiovascular diseases [1]. The
reversal  of diabetic dyslipidaemia is thus a major strategy
in  diabetes treatment [2,3].
is is an open access article under the CC BY-NC-SA license
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In many countries of the world, much attention has
een paid to ﬁnd novel types of natural anti-diabetic drugs
rom  various medicinal plants. These medicinal plants play
mportant  roles in the lives of rural people, particularly
hose in the remote parts of developing countries that have
imited  access to adequate health facilities. In addition, the
ffectiveness, limited side effects and relatively low costs
f  these medicinal plants make them to be widely pre-
cribed even when their biologically active compounds are
nknown  [4].
Livingstone potato (Plectranthus esculenthus N.E.Br)
hich is known by its local name in Nigeria as rizga, is one
f  the widely cultivated minor root crops in the middle belt
egions  especially Kaduna and Plateau States of Nigeria for
ts  ﬁnger like tubers [5]. The plant is also commonly found
n  Southern Africa, Malawi, Zimbabwe, Congo, Zambia and
sia  [5].
Livingstone potato is used in ethnopharmacology in
frica  in the treatment of digestive problems [5], stomach
che  [6], pains [7] and cancer.
In our previous study [8], we described for the ﬁrst time,
he  anti-diabetic potentials of this plant in streptozotocin
nduced diabetic rat models. However, there is no experi-
ental evidence presently available in the literature with
egard  to its effect on serum glucose, glycated hemoglobin
nd lipid proﬁles of diabetic animals. Moreover, despite
he  usage of new diagnostic devices, strict glycemic tar-
ets,  better treatment guidelines and increased awareness
f  the disease, baseline glycosylated hemoglobin has con-
inued  to remain relatively high in subjects diagnosed and
reated  for type 2 diabetes.
Since  the alteration of lipid metabolism is one of the
athological basis for the development of diabetic com-
lications and being that glycated hemoglobin is regarded
s  the best marker for glycemic control, this study was
nitiated to investigate the effect of livingstone potato on
erum  glucose, glycated hemoglobin and lipid metabolism
f  streptozotocin induced diabetes in rats.
. Materials and methods
.1.  Plant materials
The  fresh samples of livingstone potato (Plectranthus
sculenta) were obtained at harvest from National Root
rops  Research Institute (NRCRI), Umudike, Nigeria.
hey were identiﬁed by NRCRI, Umudike that has liv-
ngstone potato as a National Mandate as well as by a
axonomist in Michael Okpara University of Agriculture,
mudike, Nigeria and deposited in their herbarium for
uthentication.
.2.  Chemicals
Streptozotocin (STZ), dl-isocitric acid, -nicotinamide
denine dinucleotide phosphate-sodium salt, tri-
thanolamine, hydrochloride Gly–Gly, free base, l(−)malic
cid,  free acid, gallic acid, DPPH and standard quercetin
sed were products of Sigma and Aldrich Chemical
ompany, United Kingdom. The kits used for lipid proﬁleorts 1 (2014) 674–681 675
assays were obtained from Randox Laboratories Limited
(UK).
2.3.  Processing of the plant materials
The samples were properly washed, chopped and oven
dried  at 60 ◦C for 48 h. The dry samples were then processed
to  ﬂour and incorporated into the standard rat feeds at
19.55%  incorporation.
3.  Animal experiments
3.1.  Selection of animals
Thirty  male albino rats of the wistar strain (140–208 g)
obtained from the animal house of the Department of
Biochemistry, University of Nigeria, Nsukka, Enugu State,
Nigeria,  were used for the study. The animals were kept
in  metabolic cages in the animal house of the Department
of Biochemistry, Michael Okpara University of Agriculture,
Umudike, Nigeria. The animals were acclimatized for two
weeks  to their diets prior to the commencement of the
experiment and were maintained under a constant 12-h
light  and dark cycle and a room temperature of 27–30 ◦C.
The  National Institutes of Health Principles of Laboratory
Animal Care [9] were observed.
3.2. Induction of diabetes
After  two  weeks of acclimatization, freshly prepared
solution of streptozotocin (0.1 g dissolved in 5 ml  of freshly
prepared sodium citrate buffer 0.1 M,  pH 4.5) was injected
intraperitoneally to 24 of the rats at a dosage of 65 mg/kg
body weight at fasting state while the remaining 6 rats
were  taken as the non-diabetic groups. Blood was collected
from  the tail vein and the blood glucose concentration was
analyzed  prior to the commencement of the dietary feed-
ing  using a blood glucose meter (Double G glucometer,
USA). The STZ-treated rats with fasting blood glucose lev-
els  >200 mg/dl after twelve days of induction of STZ and
evidence of glycosuria, were considered to be diabetic and
used  for the study.
3.3.  Experimental procedure
The  STZ treated brats with stable diabetic condition
were then divided into 2 subgroups (groups 2 and 3) com-
prising  of six animals per group while the non-diabetic
group formed the ﬁrst group as follows:
Group  1. Normal rats fed standard rat feeds (Non-diabetic
control).
Group 2. Diabetic control rats which also received
standard rat feeds.
Group  3. Diabetic rats fed livingstone potato incorporated
feeds (test feed).Their diets and water were both administered ad libitum
for  28 days, after which the rats were stunned by blow, sac-
riﬁced  and blood was  drawn from their heart using 10 ml
syringes  and poured into heparin tubes for HbA1C assays
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while the rest of the blood samples were collected in non-
anti-coagulant tubes for serum assay of lipid proﬁle and
glucose.
3.4.  Biochemical analysis
The  liver was removed, washed with ice-cold phys-
iological saline immediately and stored at −20 ◦C until
analyzed. Ten percent homogenate (w/v) of the liver was
prepared in 150 mM KCl using a homogenizer at 4 ◦C [10]
and  centrifuged at 1000 × g for 5 min  to remove cell debris.
The  supernatant was further centrifuged at 14,000 × g for
30  min  at 4 ◦C and the supernatant was employed as the
enzyme source for the assay of the malic enzyme and isoc-
itrate  dehydrogenase activities of the rats [11]. The speciﬁc
activities of NADP linked malic enzyme (E.C. 1.1.1.40) and
isocitrate  dehydrogenase (EC 1.1.1.42) were determined
using the methods of Geer et al. [12] and Bergmeyer [13].
Catalase  was analyzed in the liver homogenates using the
method  of Sinha [14] and results were expressed as moles
of  H2O2 consumed/min/mg of wet liver tissue. The HbA1C
assay was carried out using the Biosysytems (Spain) diag-
nostic  kit method as described by Karl et al. [15] and the
principle was based on the quantiﬁcation of the HbA1C by
a  turbidimetric inhibition immunoassay after preparation
of  the hemolysate using tetradecyltrimethylammonium
bromide as the detergent. The serum total triglycerides,
cholesterol, glucose and HDL-cholesterol concentrations
were analyzed using the Randox assay diagnostic kits as
described  by Tietz [16] and NCEP [17]. The serum total pro-
teins  were determined using Biosystems diagnostic kits as
previously  described [18].
The LDL-cholesterol and VLDL levels were calculated
using the method of Friedewald [19]. The atherogenic index
(AI)  and coronary risk index (CRI) of the rats were cal-
culated using the formula shown below as described by
Omonkhua et al. [20]:
Atherogenic  index (AI) = LDL-cholesterol/HDL-
cholesterol; coronary risk index (CRI) = total cholesterol/
HDL-cholesterol.
3.5. Preparation of the extract of the feeds for total
phenolic assay
Six  grams each of the ﬂours of the test and standard rat
feeds  were soaked in 60 ml  of water and left overnight. The
mixtures  were ﬁltered (Whatman no. 1) and centrifuged at
3000  × g for 10 min  for the assay of the phenolic contents
of the ﬂour samples.
3.6.  Chemical analysis of the ﬂours
The total phenolic contents of the extracts of the
ﬂour samples were determined using the Folin–Ciocalteu
method as described by Singleton et al. [21]. Gallic acid was
used  as the standard and results were expressed in mg  Gal-
lic  acid equivalents/100 g. The proximate and crude ﬁber
contents of the ﬂours of the test and standard rat feeds
were determined using the methods of AOAC [22].Fig. 1. Blood glucose level of rats. Values are the means + SD of three
determinations. a–c Means with different superscripts differ signiﬁcantly
(P < 0.05) in their glucose levels.
3.7. Rapid thin layer chromatrography (TLC) free radical
scavenging screening
The  TLC screening of the antioxidant activity of the
methanolic extract of the test feed was  determined using
the  DPPH method as proposed by Mensor et al. [23] with
minor  modiﬁcations. With the aid of a capillary tube, stock
solutions (100 mg/ml) (instead of 1 mg/ml) of the extract
were  spotted on a silica gel thin layer chromatographic
(TLC) plate and developed with a solvent system of ethanol:
methanol (90:10). After development, the chromatograms
were dried and sprayed with a 0.3 mM solution of the sta-
ble  DPPH free radical. The plates were visualized for the
presence of yellow spots and the degree of activity was
determined qualitatively from observation of the yellow
colour  intensity. Yellow spot formed (within 30 min  of
spraying) against a purple background was taken as a pos-
itive  result. Quercetin was used as the positive control for
this  assay.
3.8. Statistical analysis
Data  was  subjected to analysis using the statistical
package for social sciences (SPSS), version 15.0. Results
were presented as the means ± standard deviations of three
determinations. One way  analysis of variance (ANOVA) was
used  for comparison of the means. Differences between
means were considered to be signiﬁcant at P < 0.05 using
the  new Duncan multiple range test.
4. Results
The dose of the livingstone potato used in this study that
produced the desired anti-diabetic action was 195.5 g/kg.
The serum glucose levels of the non-diabetic, dia-
betic control and diabetic rats given livingstone potato
incorporated feeds were: 92.58 ± 3.97, 352.30 ± 4.88 and
165.50  ± 7.88 mg/dl, respectively (Fig. 1). Intake of the liv-
ingstone  potato incorporated feed by the diabetic rats of
group  3, resulted in signiﬁcant reduction (P < 0.05) of their
hyperglycemia compared with the diabetic control rats
(Fig.  1).
The  percentage of glycated hemoglobin (HbA1c) of the
rats,  as shown in Fig. 2, decreased in the following order:
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Table 1
Serum lipid proﬁle (mg/dl) of rats.
Groups Chol Tri VLDL HDL LDL
Group 1 89.15 ± 13.76a 112.09 ± 23.33a 22.42 ± 4.66a 37.34 ± 6.10b 29.39 ± 6.77a
Group 2 167.95 ± 17.95b 183.23 ± 21.58b 36.65 ± 4.32b 22.01 ± 1.30a 109.30 ± 12.72c
Group 3 96.70 ± .26a 127.23 ± 14.62a 25.45 ± 2.92a 33.50 ± 3.61b 37.76 ± 1.27b
Values are means ± SD. a–c Means with different superscripts along each column are signiﬁcantly different (P < 0.05). Chol—cholesterol; Tri—triglyceride.
Fig. 2. Glycated hemoglobin status of rats. Values are the means ± SD of
three determinations. a–c Means with different superscripts differ sig-
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Fig. 3. Lipogenic enzyme activities of rats. Values are the means ± SD
of three determinations. a–c Means with different superscripts for
the  diabetic rats of group 3 resulted in signiﬁcant elevation
(P  < 0.05) of their hepatic catalase activity compared withiﬁcantly (P < 0.05) in the glycated hemoglobin contents. Biosystems
eference values (%) 4–6.5 (non-diabetic); 6.0–7.0 (goal); 7.0–8.0 (good
ontrol); >8.0 (action suggested).
iabetic control rats (9.57 ± 1.63%) > Diabetic rats given
ivingstone potato incorporated feed (8.44 ± 0.85%) > Non-
iabetic  group (6.03 ± 0.28%). The diabetic rats fed
ivingstone potato incorporated feed had signiﬁcant reduc-
ion  (P < 0.05) of their HbA1C levels compared with the
iabetic control rats (Fig. 2).
The diabetic control rats had signiﬁcant increases
P < 0.05) of their serum cholesterol, triglycerides, LDL and
LDL  levels but signiﬁcant decreases of their serum HDL
evels  compared with the non diabetic rats (Table 1).
The  diabetic rats fed the livingstone potato incorpo-
ated feed, recorded signiﬁcant reduction (P < 0.05) of their
erum  total cholesterol, triglycerides, VLDL and LDL but
igniﬁcant increase of their HDL levels compared with the
iabetic  control rats (Table 1).
The diabetic control rats had signiﬁcant increases
P < 0.05) of their atherogenic and coronary risk indices
ompared with the non diabetic rats (Table 2).
However, the diabetic rats given livingstone potato
ncorporated feed, recorded signiﬁcant reduction (P < 0.05)
f  their atherogenic and coronary risk indices compared
ith the diabetic control rats (Table 2).
The hepatic malic enzyme (ME) activities of the non-
iabetic, diabetic control and diabetic rats given livingstone
able 2
therogenic index and coronary risk index of rats (units).
Groups Atherogenic index Coronary risk index
Group 1 0.78 ± 0.06a 2.38 ± 0.13a
Group 2 4.95 ± 0.29c 7.61 ± 0.36b
Group 3 1.14 ± 0.16b 2.90 ± 0.15a
alues are means ± SD. a–c Means with different superscripts along each
olumn are signiﬁcantly different (P < 0.05). Units-ratio.each parameter are signiﬁcantly different (P < 0.05): units deﬁnition:
malic enzyme—mol of pyruvate liberated/min/g protein; isocitrate
dehydrogenase—mol of -KGT liberated/min/g protein.
potato incorporated feeds were 2.48 ± 0.4 units, 1.48 ± 0.16
units  and 2.10 ± 0.08 units, respectively, (Fig. 3) while the
hepatic  isocitrate dehydrogenase (IDH) activities of the
non-diabetic, diabetic control and diabetic rats given liv-
ingstone  potato incorporated feeds were 2.80 ± 0.43 units,
1.62  ± 0.29 units and 2.73 ± 0.53 units, respectively (Fig. 3).
There  were signiﬁcant reduction (P < 0.05) of the hepatic
malic enzyme and isocitrate dehydrogenase activities of
the  diabetic control rats compared with the non-diabetic
rats (Fig. 3).
However, there were signiﬁcant increases (P < 0.05) of
the  hepatic malic enzyme and isocitrate dehydrogenase
activities of the diabetic rats given livingstone potato incor-
porated  feeds compared with the diabetic control rats
(Fig.  3).
The  diabetic control rats had signiﬁcant reduction
(P < 0.05) of their hepatic catalase activities compared with
the  non-diabetic rats (Table 3).
Intake of the livingstone potato incorporated feed bythe  diabetic control rats (Table 3).
Table 3
Hepatic catalase activity of rats.
Groups Catalase (mol  of H2O2
consumed/min/mg of wet liver
tissue)
Non-diabetic 82.40 ± 3.52c
Diabetic control 40.75 ± 4.77a
Diabetic + livingstonepotato 57.20 ± 3.97b
a–c Values are the means ± SD of triplicate experiments. Means with dif-
ferent superscripts are signiﬁcantly different (P < 0.05).
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Table  4
Body  weight of rats (g).
Groups Initial weight Final weight
Group 1 185.50 ± 4.95ab 233.00 ± 4.24c
Group 2 156.50 ± 16.26b 102.50 ± 7.78a
Group 3 207.00 ± 1.41b 179.00 ± 1.41b
a–c Means with different superscripts along each column are signiﬁcantly
different (P < 0.05).
Table 6
Free  radical scavenging activities of the methanolic/ethanolic extracts of
livingstone potato incorporated feed using Rapid DPPH TLC screening.
Plants Antioxidant activity Intensity of spot
Livingstone potato Strong +++
Quercetin  Strong +++
of  cholesterol, triglycerides, VLDL and LDL in the diabeticFig. 4. Phenolic and crude ﬁber composition of standard and livingstone
potato incorporated feed. Values are the means ± SD of three determina-
tions.
The body weights of the diabetic control rats were
signiﬁcantly reduced (P < 0.05) compared with the non-
diabetic rats while the body weights of the diabetic rats
given  the livingstone potato incorporated feed were sig-
niﬁcantly increased (P < 0.05) compared with the diabetic
control rats (Table 4).
The  feed intake of the diabetic control rats was not sig-
niﬁcantly different (P > 0.05) from that of the non-diabetic
rats by the last week of experimentation while the feed
intake  of the diabetic rats given the livingstone potato
incorporated feed was signiﬁcantly higher (P < 0.05) than
that  of the diabetic control rats by the last week of experi-
mentation (Table 5).
Proximate  analysis of the livingstone potato incor-
porated and standard feeds showed that the standard
rat feed contained 15.00 ± 0.78% protein, 7.24 ± 1.20%
fat,  31.55 ± 2.62% carbohydrates with an energy value
of  290.65 ± 4.77 kcal/100 g while the livingstone potato
incorporated feed contained 40.10 ± 0.16% carbohydrates,
17.22 ± 0.40% protein, 22.16 ± 0.34% fat with an energy
value of 428.70 ± 2.12 kcal/100 g.
Phytochemical and crude ﬁber analysis of the liv-
ingstone potato incorporated and standard rat feeds
revealed that the livingstone potato incorporated feed con-
tained  1.3 ± 0.2 mg  gallic acid equivalent/g of sample and
8.51  ± 0.16% crude ﬁber while the standard rat feed con-
tained  0.12 ± 0.04 mg  gallic acid equivalent and 10% crude
ﬁber  (Fig. 4).
Table 5
Feed  intakes per rat (g/week).
Groups Week 1 Week 2 
Group 1 118.22 ± 7.43a 127.05 ± 8.97b
Group 2 117.07 ± 5.88a 121.95 ± 9.11b
Group 3 119.56 ± 2.54a 106.29 ± 5.75a
Values are means ± SD. a–c Means with different superscripts along each column The degree of antioxidant activity, determined qualitatively from the
observation of the yellow colour intensity: strong (+++).
Antioxidant screening of the methanolic/ethanolic
extract of the livingstone potato incorporated feed using
rapid  thin layer chromatographic assay indicated that
it  possessed strong antioxidant activity comparable to
standard quercetin (Table 6).
5. Discussion
The STZ rat model of diabetes is one of the most com-
monly used models of human disease [24] because it
mimics many of the complications of human diabetes.
The reduction of the serum glucose of the diabetic rats
fed  the test plant to the extent that was  observed in this
study  is an indication of the ameliorating potentials of liv-
ingstone  potato on hyperglycemia.
Glycated hemoglobin (HbA1C) is a product of the
irreversible condensation of glucose with the N-terminal
residue of the -chain of hemoglobin A. The level of gly-
cated hemoglobin is a useful and reliable tool for the
assessment of glycemic control in diabetics as recom-
mended by the International Diabetes Federation [25] as it
reﬂects  the average blood glucose concentration over the
preceding 6–8 weeks [26–28], equivalent to the life time of
the  erythrocytes.
Several authors have reported the ameliorating actions
of  different anti-diabetic plants on the HbA1C status of
streptozotocin diabetic rat models in short term studies
[29–31].
Although the duration of this study was  short, the sig-
niﬁcant reduction of the HbA1C levels of the diabetic rats
fed  the test feed underscores the importance of livingstone
potato in the dietary management of diabetes and its com-
plications since reduction of glycated hemoglobin is known
to  decrease diabetic complications [32].
Hypercholesterolemia and hyper-triglyceridemia are
recognized complications of diabetes mellitus [33,34]
resulting from alterations in lipid metabolism character-
ized by elevated levels of cholesterol, triglycerides, VLDL
and  LDL and this could account for the elevated levelsuntreated rats.
Studies  have shown that atherogenic index is a good
predictor of cardiovascular disease risk as well as efﬁcient
Week 3 Week 4
122.00 ± 12.37b 133.34 ± 1.32a
119.60 ± 3.99a 137.84 ± 5.77a
140.24 ± 0.88c 146.38 ± 4.33b
are signiﬁcantly different (P < 0.05).
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onitor of the effectiveness of lipid-lowering therapies
ince the LDL/HDL ratio has been considered more progno-
tic  than LDL or HDL alone [34].
The signiﬁcant reduction of the serum total cholesterol,
LDL, triglycerides, LDL-cholesterol, atherogenic and coro-
ary  risk indices together with the concomitant signiﬁcant
ncrease in the HDL levels of the diabetic rats fed the test
eed,  indicate the anti-hyperlipidemic potentials of living-
tone  potato.
The  triglyceride lowering property of livingstone potato
s  observed in this study could indirectly have contributed
o  its anti-hyperglycemic activity through the mechanism
f  the glucose-fatty acid cycle [35] which reports that
ncreased supply of triglycerides could constitute a source
f  increased free fatty acid availability and oxidation that
an  impair insulin action, glucose metabolism and uti-
ization, leading to the development of hyperglycemia.
herefore, reduction of triglycerides after feeding of liv-
ngstone potato incorporated feed would also facilitate
lucose oxidation, utilization and subsequently reduction
f  hyperglycemia.
Malic enzyme catalyzes the oxidative decarboxylation
f cytoplasmic malate [10,26]. The reaction helps to trans-
er  cytoplasmic oxaloacetate to the mitochondrion which
s  important in the TCA cycle for the formation of citrate
ith  acetyl-CoA for generating malate which can feed the
ytosolic  gluconeogenic pathway [10,36].
Isocitrate dehydrogenase catalyzes the oxidative decar-
oxylation of isocitrate to  ketoglutarate and requires
ither NAD+ or NADP+, producing NADH and NADPH,
espectively [37]. It is another key regulatory enzyme in
ipogenesis, which supplies the NADH from the extra mito-
hondrial  space for the generation of NADPH through the
ctivity  of the malic enzyme.
During  diabetes, lipogenesis is decreased while lipol-
sis  is increased in the hepatic tissue which results from
he  underutilization of glucose resulting in increased lipol-
sis  [38] and this explains the reduced hepatic levels of
he  lipogenic enzymes-ME and IDH in the diabetic con-
rol  rats. Similar kinds of results were reported [26,39].
his decrease to the extent that was observed in this study
ould  lead to decreased generation of NADPH needed for
he  regeneration of glutathione and other reducing agents
hat  are needed for the maintenance of tissue integrity and
xidative  balance.
However, the increased hepatic ME  and IDH activities of
he  diabetic rats fed livingstone potato incorporated feed
ndicates  better utilization of glucose or energy yielding
ntermediates by the TCA cycle [38].
Results obtained in this study indicate that treatment of
iabetics  with livingstone potato increases the utilization
f  circulating glucose by the liver.
The loss of weight by the diabetic control rats despite
ncreased feed intake is an indication of loss of tissue pro-
eins  that contribute to body weight while the increase in
eight  by the diabetic rats fed the livingstone potato incor-
orated  feed is simple due to treatment of hyperglycemia.
The recommended daily allowance for fat in diabetic
atients is 15–20% of the total calorie [40]. Crude fat pro-
ided  about 22.16% of the total calories of the livingstone
otato incorporated feed and 7.24% of the total calories oforts 1 (2014) 674–681 679
the  standard rat feed. The implication is that while the
fat  content of the standard rat feed failed to meet the
daily requirement, the fat content of the livingstone potato
incorporated feed did.
Crude  protein provided about 15% of the total calories
of the standard rat feed and about 17.22% of the livingstone
potato incorporated feed.
The recommended daily allowance for proteins in dia-
betic  patients is 15–20% of the total calories [40]. Thus, the
range  of proteins in both the standard rat feed and the
livingstone potato incorporated feed did meet with this
requirement.
It  is worth noting that despite containing large amount
of  proteins, consumption of the standard rat feeds by the
diabetic  control rats did not translate into weight gain
which is a conﬁrmation that the loss of weight by the dia-
betic  control rats despite eating highly proteinous diet was
as  a result of uncontrolled hyperglycemia while the gain
in  weight after feeding of livingstone potato incorporated
feed resulted from glycemic control [41].
Total carbohydrates provided approximately 40.1% of
the  total calories for the livingstone potato incorporated
feed and 31.55% of the total calories for the standard rat
feed.  Values obtained for both feed samples were lower
than  the recommended daily allowance for carbohydrates
(50–70% of total calories) in diabetics [40].
Energy value of a food measures its value to the body as
a  fuel. The test feed was  observed to contain higher energy
value  than the standard rat feed.
Phenolics have received considerable attention because
of  their potential antioxidant activity and effects on
carbohydrate metabolism involving the inhibition of -
glucosidase and -amylase, the key enzymes responsible
for digestion of dietary carbohydrates to glucose [42].
Another important action of polyphenols on cardio-
vascular system in diabetes is the regulation of lipid and
lipoprotein metabolism with resultant improvement of
dyslipidemia [43].
The  higher phenolic content of the livingstone potato
incorporated feed compared with the standard rat feed,
could  be one explanation for the higher anti-diabetic and
anti-hyperlipidemic actions demonstrated by livingstone
potato compared with the standard rat feed in this study.
Oxidative stress has recently been implicated in pan-
creatic -cell dysfunction. Several reaction mechanisms
are thought to be involved in the genesis of oxidative
stress in both diabetic patients and diabetic animals and
they  include: glucose auto-oxidation, protein glycation,
formation of advanced glycation products and the polyol
pathway. The production of reactive oxygen species during
these  processes leads to tissue damage [44].
The decrease in the hepatic catalase activity of the dia-
betic  control rats to the extent that was observed in this
study  could precipitate oxidative stress to the liver while
the  increased hepatic catalase activity of the diabetic rats
fed  the livingstone potato incorporated feed shows that
intake  of livingstone potato by diabetics could protect the
liver  from oxidative damage.
The  strong antioxidant activity of the methano-
lic/ethanolic extract of the livingstone potato incorporated
feed could be the explanation for the modulation of the
logy Re
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hepatic antioxidant status of the diabetic rats fed the living-
stone  potato incorporated feed. Furthermore, this strong
antioxidant activity could be attributed to the phenolic con-
tent  of the livingstone potato incorporated feed.
Dietary ﬁber decreases the absorption of cholesterol
from the gut in addition to delaying the digestion and con-
version  of starch to simple sugars, an important factor in
the  management of diabetes. Dietary ﬁbred also functions
in  the protection against cardiovascular disease, colorectal
cancer and obesity [45].
However,  it was observed that the crude ﬁber contents
of  the standard rat feeds were higher than that of the liv-
ingstone potato incorporated feed.
It is therefore plausible to suggest that the hypoglycemic
and anti-hyperlipidemic actions demonstrated by living-
stone  potato in this study could be directly related to its
phenolic constituents.
6.  Conclusion
Results obtained in this study, indicate the anti-
hyperlipidemic potentials of livingstone potato. The
signiﬁcant reduction of the HbA1C levels of the diabetic
rats fed the livingstone potato incorporated feeds under-
scores the importance of livingstone potato in the dietary
management of diabetes mellitus and its complications.
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